OTCM
PHBID
Market cap69kUSD
Oct 19, Last price
0.20USD
1D
0.00%
1Q
-88.89%
IPO
-100.00%
Name
Pharmagreen Biotech Inc
Chart & performance
P/E
0.17
P/S
28.95
EPS
1.18
Div yield, %
—
Shs. 5Y
-61.90%
Rev. 5Y
%
Revenues
2k
-29.97%
Net income
406k
P
CFO
-23k
L-17.03%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
Key people
Fawzia Afreen
Chief Operating Officer of WFS Pharmagreen Inc. · since 2018
Terry Kwan
Chief Financial Officer, Director of WFS Pharmagreen Inc. · since 2022
Peter Wojcik
President, Director; Chief Executive Officer, Director of WFS Pharmagreen Inc. · since 2018
Headquarters & legal address
112 NORTH CURRY STREET
Carson City, NV 89703
US
Carson City, NV 89703
US
Previous name
AIR TRANSPORT GROUP HOLDINGS, INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||